News | May 11, 2024
Dr. Lal PathLabs posts Q4 FY24 consolidated PAT at Rs. 84.5 Cr
The company has posted net profit of Rs.357.7 crores for the Financial Year ended March 31, 2024
The company has posted net profit of Rs.357.7 crores for the Financial Year ended March 31, 2024
The company has posted net profit) of Rs.18.88 crores for the Financial Year ended March 31, 2024
The company has posted net profit of Rs. 1,201.22 crores for the Financial Year ended March 31, 2024
The company has posted net profit of Rs.8.29 crores for the Financial Year ended March 31, 2024
The company has posted net profit of Rs.615.82 crores for the Financial Year ended March 31, 2024
The company has posted net profit of Rs.118.82 crores for the Financial Year ended March 31, 2024
The company has posted net profit of Rs.171.42 crores for the Financial Year ended March 31, 2024
With this, for all our USFDA facilities, EIRs are in place
The company has posted net loss of Rs. 105.07 crores for the Financial Year ended March 31, 2024
The brand has also unveiled a new TVC campaign in Telangana and Andhra Pradesh to drive brand awareness
Subscribe To Our Newsletter & Stay Updated
